Cite
Assessment of overall survival in glioma patients as predicted by metabolomic criteria
MLA
Sebastián Cerdán, et al. Assessment of Overall Survival in Glioma Patients as Predicted by Metabolomic Criteria. May 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....df31454f86b521dfb51246e69173d527&authtype=sso&custid=ns315887.
APA
Sebastián Cerdán, Pilar López-Larrubia, Maria L Gandía-González, Laura Barrios, Pablo García Feijoo, Alexis Junnior Palpan, Juan Solivera, & José M. Roda. (2019). Assessment of overall survival in glioma patients as predicted by metabolomic criteria.
Chicago
Sebastián Cerdán, Pilar López-Larrubia, Maria L Gandía-González, Laura Barrios, Pablo García Feijoo, Alexis Junnior Palpan, Juan Solivera, and José M. Roda. 2019. “Assessment of Overall Survival in Glioma Patients as Predicted by Metabolomic Criteria,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....df31454f86b521dfb51246e69173d527&authtype=sso&custid=ns315887.